Vir Biotechnology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-66.4M | $-69.1M | $2.7M | $4.8M |
| FY2018 | $-94.1M | $-102.3M | $8.2M | $5.1M |
| FY2019 | $-129.6M | $-138.6M | $8.9M | $8.7M |
| FY2020 | $-190.9M | $-197.5M | $6.5M | $27.6M |
| FY2021 | $-47.6M | $-69.4M | $21.8M | $83.8M |
| FY2022 | $1.66B | $1.60B | $68.0M | $102.1M |
| FY2023 | $-778.8M | $-800.4M | $21.6M | $111.3M |
| FY2024 | $-446.4M | $-453.7M | $7.3M | $78.5M |
| FY2025 | $-391.8M | $-396.6M | $4.8M | $49.1M |